Johnston S L, Perry D, O'Toole S, Summers Q A, Holgate S T
Immunopharmacology Group, Southampton General Hospital.
Thorax. 1992 Aug;47(8):592-7. doi: 10.1136/thx.47.8.592.
Prior treatment with local hyperthermia has been shown to prevent mast cell degranulation and leucocyte histamine release, and to reduce mortality and cellular infiltrates in a model of acute lung injury. Local hyperthermia is effective in reducing the symptoms of the common cold and perennial and seasonal allergic rhinitis, nasal patency also being improved in rhinitis. It is possible that these effects are mediated by common anti-inflammatory mechanisms, and that this treatment may be effective in the treatment of asthma. The effect of prior local hyperthermia on the response to exercise challenge and histamine bronchoprovocation was therefore examined.
In a randomised, double blind, placebo controlled, crossover study, 10 asthmatic subjects with exercise induced asthma used machines delivering 40 1/minute of fully humidified air at either 42 degrees C (active treatment) or 31 degrees C (placebo treatment) for 30 minutes' tidal breathing. For each pretreatment, at two week intervals they underwent exercise challenges starting one and 24 hours after starting the inhalations. After a further two weeks the protocol was repeated with histamine substituted for the exercise challenges.
The mean (SE) maximum percentage fall in forced expiratory volume in one second (FEV1) was significantly lower one hour after treatment with air at 42 degrees C (30.8% (3.1%)) than after treatment with air at 31 degrees C (22.3% (2.9%)). There was no significant effect on exercise challenge at 24 hours, or on histamine challenge at either time point, though there were nonsignificant trends towards protection with exercise at 24 hours and with histamine at one hour.
In asthmatic subjects the response to exercise challenge is significantly attenuated one hour after treatment with local hyperthermia. This treatment warrants further investigation in the treatment of clinical asthma and other inflammatory disorders.
先前的研究表明,局部热疗可预防肥大细胞脱颗粒和白细胞组胺释放,并可降低急性肺损伤模型中的死亡率和细胞浸润。局部热疗在减轻普通感冒、常年性和季节性变应性鼻炎症状方面有效,同时也能改善鼻炎患者的鼻通气。这些作用可能是由共同的抗炎机制介导的,并且这种治疗方法可能对哮喘治疗有效。因此,研究了预先进行局部热疗对运动激发试验和组胺支气管激发试验反应的影响。
在一项随机、双盲、安慰剂对照的交叉研究中,10名运动诱发性哮喘患者使用机器,以42℃(主动治疗)或31℃(安慰剂治疗)输送每分钟40升的完全湿化空气,进行30分钟的潮气呼吸。对于每次预处理,每隔两周,在开始吸入后1小时和24小时开始进行运动激发试验。再过两周后,重复该方案,用组胺替代运动激发试验。
在使用42℃空气治疗1小时后,一秒用力呼气容积(FEV1)的平均(SE)最大下降百分比(30.8%(3.1%))显著低于使用31℃空气治疗后(22.3%(2.9%))。在24小时时对运动激发试验无显著影响,在两个时间点对组胺激发试验也无显著影响,尽管在24小时运动激发试验和1小时组胺激发试验时有不显著的保护趋势。
在哮喘患者中,局部热疗治疗1小时后,运动激发试验的反应显著减弱。这种治疗方法值得在临床哮喘和其他炎症性疾病的治疗中进一步研究。